Oncolix Inc. (fka ONCX)

[steadyhand]

Did anyone notice this new line on the website...


The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer. This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat.


Once Redman doses the next group then drops the efficacy information (meaning not only is the drug safe but it helped slow down/ kill some of the cancer) that will be huge.

You know they have tricks up their sleeve once this name is changed. They need to raise another 30 million to get this thing thru phase II. The only way to do that is get to a market cap in the hundreds of millions and sell into it.